Oramed Pharmaceuticals Inc (ORMP) — Working Capital to Net Assets Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Working Capital to Net Assets ratio of 133.5% as of December 2025. Working capital of $114.19 Million (current assets of $133.27 Million minus current liabilities of $19.09 Million) is measured against net assets of $85.56 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Oramed Pharmaceuticals Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Oramed Pharmaceuticals Inc Working Capital to Net Assets (2005–2025)
This chart shows how Oramed Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 133.5%, reflecting working capital of $114.19 Million against net assets of $85.56 Million USD. Check ORMP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Oramed Pharmaceuticals Inc (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Oramed Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Oramed Pharmaceuticals Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 133.5% | $114.19 Million | $85.56 Million | $133.27 Million | $19.09 Million | ▲ +38.8 pp |
| 2024 | 94.6% | $137.54 Million | $145.35 Million | $143.22 Million | $5.68 Million | ▲ +27.5 pp |
| 2023 | 67.1% | $109.37 Million | $162.89 Million | $162.58 Million | $53.21 Million | ▼ -33.0 pp |
| 2022 | 100.1% | $151.36 Million | $151.16 Million | $157.11 Million | $5.75 Million | ▲ +24.0 pp |
| 2021 | 76.1% | $88.66 Million | $116.52 Million | $95.34 Million | $6.68 Million | ▼ -33.3 pp |
| 2020 | 109.4% | $35.98 Million | $32.88 Million | $40.51 Million | $4.54 Million | ▼ -35.0 pp |
| 2019 | 144.5% | $28.02 Million | $19.39 Million | $33.32 Million | $5.31 Million | ▲ +59.3 pp |
| 2018 | 85.1% | $26.48 Million | $31.11 Million | $31.04 Million | $4.55 Million | ▲ +6.5 pp |
| 2017 | 78.7% | $15.13 Million | $19.24 Million | $20.30 Million | $5.17 Million | ▼ -26.8 pp |
| 2016 | 105.4% | $27.61 Million | $26.19 Million | $31.23 Million | $3.62 Million | ▲ +41.4 pp |
| 2015 | 64.0% | $15.88 Million | $24.83 Million | $17.37 Million | $1.49 Million | ▼ -36.1 pp |
| 2014 | 100.1% | $20.80 Million | $20.79 Million | $21.78 Million | $973.00K | ▼ -0.1 pp |
| 2013 | 100.2% | $8.15 Million | $8.13 Million | $8.64 Million | $498.19K | ▼ -22.4 pp |
| 2012 | 122.6% | $4.63 Million | $3.78 Million | $5.28 Million | $644.42K | ▲ +19.4 pp |
| 2011 | 103.2% | $3.84 Million | $3.72 Million | $4.28 Million | $441.29K | ▼ -9.8 pp |
| 2010 | 113.0% | $938.23K | $830.27K | $1.40 Million | $458.58K | ▲ +10.8 pp |
| 2009 | 102.2% | $2.81 Million | $2.75 Million | $3.17 Million | $368.60K | ▲ +4.5 pp |
| 2008 | 97.6% | $4.48 Million | $4.59 Million | $5.40 Million | $913.95K | ▼ -1.0 pp |
| 2007 | 98.6% | $506.00K | $513.00K | $1.93 Million | $1.42 Million | ▼ -1.4 pp |
| 2006 | 100.0% | $-432.72K | $-432.72K | $176.19K | $608.91K | ▲ +0.0 pp |
| 2005 | 100.0% | $-44.81K | $-44.81K | $1.26K | $46.07K | — |